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BACKGROUND: Radon is the second most important cause of lung cancer, ranked by the World Health Organization as the fifth leading cause of mor-
tality in 2010. An updated database of national radon exposures for 66 countries allows the global burden of lung cancer mortality attributable to ra-
don to be estimated. 
OBJECTIVE: Our goal was to estimate the global population attributable burden of lung cancer mortality in 2012 from residential radon. 
METHODS: Estimates of the population attributable risk (PAR) of lung cancer mortality from radon were determined using the attributable fraction 
approach, using three models for excess relative risk of lung cancer from radon. 
RESULTS: The estimates of the median PAR of lung cancer mortality from residential radon in 2012 for the 66 countries having representative national 
radon surveys were consistent, as 16.5%, 14.4%, and 13.6% for the exposure–age–concentration (EAC) model (BEIR VI), the Hunter model, and the 
Kreuzer model, respectively. The mean PAR using the EAC model ranged from 4.2% (95% CI: 0.9, 11.7) for Japan, to 29.3% (95% CI: 22.9, 35.7) 
for Armenia, with a median for the 66 countries of 16.5%. Radon-attributable lung cancer deaths for all 66 countries totaled 226,057 in 2012 and rep-
resent a median of 3.0% of total cancer deaths. 
CONCLUSIONS: Consistent findings between the three models used to estimate excess relative risks of lung cancer from radon, and between the attrib-
utable fraction methodology and the life table analysis, confirm that residential radon is responsible for a substantial proportion of lung cancer mortal-
ity worldwide. https://doi.org/10.1289/EHP2503 
Introduction 
Radon is the second most important cause of lung cancer, after 
smoking (WHO 2006). Radon-222 and its decay products were 
classified as a known cause of human cancer by the International 
Agency for Research on Cancer (IARC) in 1988 (IARC 2012). 
Radon-222 is a colorless, odorless, radioactive gas that occurs 
naturally when the uranium-238 present in rock and soil under-
goes radioactive decay. The short-lived radon progeny (or decay 
products) are also radioactive. The alpha radiation emitted by ra-
don progeny inhaled into the lungs can damage cellular DNA, 
which can eventually result in clinically evident lung cancer. 
Radon can accumulate in poorly ventilated buildings, especially 
in basements, when radon from the ground seeps in through entry 
points such as cracks in the foundations. 
Strong and complementary evidence of the risks of lung cancer 
from cumulative exposure to radon and its progeny via inhalation 
have been determined from studies of occupational exposures of 
uranium miners and residential exposures of the public (Tirmarche 
et al. 2010). An inverse dose–rate effect was reported in the analy-
sis of pooled data from 11 cohort studies of radon-exposed miners 
reviewed by Lubin et al. (1995). The risk to miners exposed at 
lower doses initiated studies of the risk to the general public from 
residential radon. Evaluation of the lower residential radon expo-
sures of the pooled case–control studies yielded results consistent 
with those from the miner studies, and showed that the odds ratio 
of lung cancer generally increased with radon concentration and 
was consistent with linearity. After adjustments for uncertainties in 
radon measurements, the excess risk ratio (ERR) was 0.16 [95% 
confidence interval (CI): 0.05, 0.31] for European pooling (Darby 
et al. 2006) and the excess odds ratio (EOR) was 0.18 (95% CI: 
0.02, 0.43) per 100 Bq=m3 for North American pooling (Krewski 
et al. 2006). Recent estimates of ERR per working level month 
(ERR/WLM) were derived from studies of miners having low ra-
don exposure rates and low cumulative exposures similar to those 
from residential radon: ERR=WLM = 0:017 (95% CI: 0.009, 
0.0035) from three European nested case–control miner studies re-
stricted to cumulative exposures <300 WLM (Hunter et al. 2013); 
and ERR=WLM = 0:013 (95% CI: 0.009, 0.0035) from a German 
miner cohort with mean cumulative exposure of 17 WLM (range: 
0–334 WLM) (Kreuzer et al. 2015). WLM, working level month, 
is a cumulative exposure defined as breathing a concentration of 
1 working level (WL; 2:08 × 10−5 J=m3) for a working month of 
170 h. (1 WLM = 6:37 × 105Bq=m3 per hour for equilibrium equiva-
lent concentration of radon. 
The global burden from lung cancer mortality is significant 
and steadily increasing. The World Health Organization (WHO) 
Global Burden of Disease (GBD) reported that trachea, bronchus, 
and lung cancers represented 19% of all cancer deaths and ranked 
as the fifth leading cause of death worldwide (Lozano et al. 
2012). Although the age-standardized lung cancer mortality rate 
decreased by 9%, the number of lung cancer deaths increased by 
57% between 1990 and 2013, primarily due to the aging of the 
population in low- and middle-income countries (Naghavi et al. 
2015). The goal of this research was to compare estimates 
of the number, the percentage of total cancer deaths, and the 
population attributable risk (PAR) for lung cancer mortality in 




The global burden of lung cancer mortality attributed to residen-
tial radon was estimated for the 66 countries that have conducted 
a representative national radon survey. The lung cancer mortality 
attributable to radon was estimated from the attributable fraction 
approach, using three different models to calculate the excess rate 
ratio from radon: the BEIR VI (sixth Committee on Biological 
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Effects of Ionizing Radiation) exposure–age–concentration (EAC) 
model (NRC 1999), the Hunter et al. (2013) model, and the 
Kreuzer et al. (2015) model. Estimates of the mean and 95% CIs 
were determined for the PAR and the number of lung cancer 
deaths attributable to radon, with the uncertainty assessed using 
Monte Carlo simulation with 10,000 replications to sample the 
national distributions for residential radon and adult smoking prev-
alence for men and women and probabilistic distributions for the 
excess rate ratio models. 
National Assessment of Lung Cancer Mortality Attributed to 
Residential Radon 
National radon exposure. The International Atomic Energy 
Agency (IAEA) has summarized the methodology and measure-
ment techniques suitable for indoor radon surveys that are repre-
sentative of a national or regional population (IAEA 2013). An 
estimate of either arithmetic or geometric mean (GM) national 
residential radon exposure was included in the updated database 
if it resulted from a systematic survey using a reliable radon mea-
surement technique. The Medline database was searched on 20 
May 2017, using MeSH terms and keywords “Radon Daughters/ 
or Radon/” and “residential.mp.”, published between 2000 and 
2017. Of the 1,599 papers identified, 27 were used to update the 
United Nations Scientific Committee on the Effects of Atomic 
Radiation (UNSCEAR) 2000 and 2006 databases (original sour-
ces referenced when provided). Radon distributions for the 66 
countries included in the analysis are shown in Table 1 and the 
references listed in Table S1. The lognormal distribution [defined 
by the geometric mean (GM) and geometric standard deviation 
(GSD)] characterizing the residential radon for each country is 
sampled in the Monte Carlo simulation to provide a probabilistic 
estimate of the mean and 95% CIs of the lung cancer mortality at-
tributable to radon. For the 22 countries with incomplete radon 
data, the geometric standard deviation (GSD) was imputed from 
the mean based on linear regression of the data from countries 
reporting both a mean and a GSD. 
Lung cancer mortality by smoking status.  National lung can-
cer mortality is reported at the detailed age- and sex-specific 
country-level in the WHO/IARC GLOBOCAN project for 2012: 
Estimated Cancer Incidence Mortality and Prevalence Worldwide 
in 2012 (IARC 2012). The 10th revision of the International 
Statistical Classification of Diseases and Related Health Problems 
(ICD-10) codes for malignant neoplasm of bronchus and lung are 
C33–34. National smoking prevalence in 2012 among adult men 
and women, >15 y of age, was obtained from the WHO Global 
Health Observatory data for prevalence of tobacco smoking (WHO 
2012) and is shown in Table S2. The smoking prevalence for the 
nine countries missing adult data was imputed from similar coun-
tries using linear regression, and thus expected to contribute little to 
overall uncertainty. Lung cancer mortality was adjusted for smoking 
using the relative risk of lung cancer mortality for smoker versus 
nonsmokers and the adult smoking prevalence in each country 
(Tirmarche et al. 2010; Villeneuve and Mao 1994). The relative risk 
of lung cancer mortality for smokers versus nonsmokers (RRe) by 
sex and age category reported by the American Cancer Society 
Cancer Prevention Study (CPS)-II (Thun et al. 1997) was used for 
all countries. 
Excess rate ratio. Three different models are used to calculate 
the excess rate ratio from radon derived from the miner cohort stud-
ies because they are characterized by very good radon exposure 
assessment and annual measurements over long periods of occupa-
tional exposure. The BEIR VI EAC model is based on over one mil-
lion person-years of observation, and the recent Hunter and Kreuzer 
models are based on low radon exposure rates and cumulative doses 
that approximate those resulting from lifetime residential exposures. 
The models used to calculate the excess rate ratio from radon 
include: a) the BEIR VI EAC model (NRC 1999) based on 11 miner 
cohorts, the most complete model that also fits low cumulative 
exposures; b) the model derived from three European nested case– 
control miner studies restricted to exposures <300 WLM (Hunter 
et al. 2013); and c) the model derived from a German miner cohort 
having low radon exposures rates, characterized by a mean cumula-
tive exposure of 17 WLM, mean individual average radon exposure 
rate of 0.2 WL, and mean duration of employment of 10 y (Kreuzer 
et al. 2015). 
The ERR/WLM is 0.08 (GSD = 1:36) for the BEIR VI EAC 
model, modified by factors for smoking status, effective exposure 
duration, exposure-rate effect, and attained age. Central estimates 
of the parameter values for the modifying factors were derived 
from an overall fit of the BEIR VI EAC model to 11 miner cohort 
studies taken from Krewski et al. (1999), as described in greater 
detail in Brand et al. (2005). For the Hunter et al. (2013) model re-
stricted to <300 WLM, the ERR/WLM is 0.043 (95% CI: 0.022, 
0.08) and 0.007 (95% CI: 0.002, 0.018), for time since exposure of 
5–25 y and >25 y, respectively, and is also modified by a factor for 
attained age. The ERR/WLM is 0.013 (95% CI: 0.007, 0.021) for 
the unrestricted Kreuzer et al. (2015) model, based on cumulative 
radon exposures ranging from 0 to 334 WLM. 
The three excess rate ratio models of lung cancer mortality 
used in this analysis are applied to lifetime radon exposure and 
assessed for each age group in the population, assuming constant 
residential radon exposure and a 5-y latency period. The residen-
tial radon exposure [in becquerels per cubic meter (Bq=m3)] is 
converted into working level months for use in the miner excess 
rate ratio models, assuming an equilibrium factor of 0.4 and 
7,000 h per year indoors at home lead to 1 Bq=m3 radon exposure 
for 1 y equaling 0.0044 WLM at home. The BEIR VI EAC model 
uses relative weights to progressively diminish the contribution 
of radon exposure >15 y and >25 y prior to lung cancer, and the 
Hunter et al. (2013) model reported a contribution at one-sixth 
for exposure >25 y prior to the outcome (ERR=WLM = 0:007 
for exposure >25 y prior). Although double the risk for non-
smokers than current smokers was reported in the Hunter model 
and a higher risk estimate for non/light smokers than for moder-
ate/heavy smokers was reported in the Kreuzer model, neither 
model includes a factor for smoking status because the differen-
ces were not statistically significant. 
Estimates of PAR are derived from the pooled residential studies 
(adjusted for uncertainties in radon measurement) by first convert-
ing each reported ERR to an excess rate ratio using cumulative ra-
don exposure, ERR/WLM. The excess rate ratio for the residential 
studies was assumed to be contributed primarily from the period 5– 
25 y prior to lung cancer, with the model extended to lifetime expo-
sure using the estimate reported by Hunter et al. (2013) for expo-
sures >25 y prior to lung cancer of ERR=WLM = 0:007. The 
estimate for the period 5–25 y prior to lung cancer from the pooled 
North American study was ERR=WLM = 0:018, based on of 
ERR = 0:18 per 100 Bq=m3 radon from Krewski et al. (2006), and 
from the pooled European study was ERR=WLM = 0:014, based on 
ERR = 0:16 per 100 Bq=m3 radon from Darby et al. (2006). 
Attributable number and risk of lung cancer deaths. The 
excess rate ratio attributable to radon is calculated for each sex– 
age–smoking category and the attributable fraction is calculated 
using Equation 1: 
AF =
excess rate ratio
1 + excess rate ratio
: (1)  
The attributable fraction is multiplied by the number of lung 
cancer deaths for each age–sex–smoking category to determine the 
number of radon-attributable lung cancer deaths. For each country, 
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Table 1. Radon population attributable risk (PAR) of lung cancer mortality. 
Country 
Radona [GM (GSD)]  
(Bq=m3) 
PAR (%), BEIR VIb  
[mean (95% CI)] 
PAR (%), Hunterc  
[mean (95% CI)] 
PAR (%), Kreuzerd  
[mean (95% CI)] 
Attributable number  
lung cancer deaths,  
BEIR VIb [mean (95% CI)] 
Total Cancer  
Deathse (%)   
Median   38   16.5   14.4   13.6   630   3.0 
Albania   75 (2.2)   23.5 (8.1, 36.6)   24.4 (6.8, 37.5)   23.2 (12.5, 32.1)   246 (85, 383)   5.2 
Algeria   22 (2.2)   15.8 (3.4, 37.0)   9.0 (2.2, 15.1)   8.3 (4.1, 12.3)   376 (82, 882)   1.7 
Argentina   27 (2.2)   13.6 (3.1, 30.7)   10.8 (2.6, 18.0)   10.0 (4.9, 14.7)   1,434 (324, 3,234)   2.2 
Armenia   101 (1.3)   29.3 (22.9, 35.7)   30.1 (9.1, 44.6)   28.9 (16.2, 39)   415 (325, 508)   6.1 
Australia   8.7 (2.1)   4.7 (0.9, 13.7)   3.7 (0.8, 6.5)   3.5 (1.6, 5.2)   384 (77, 1,128)   0.9 
Austria   61 (2.7)   20.9 (1.4, 53.4)   21.0 (5.6, 32.9)   19.8 (10.4, 27.8)   764 (51, 1,954)   3.7 
Belarus   23 (2.2)   13.4 (2.9, 32.0)   9.5 (2.3, 15.9)   8.8 (4.3, 12.9)   459 (99, 1,096)   2.4 
Belgium   38 (2.0)   15.2 (4.4, 29.1)   14.3 (3.5, 23.3)   13.5 (6.8, 19.4)   1,093 (318, 2,088)   3.7 
Brazil   30 (2.2)   15.9 (3.7, 33.7)   11.8 (2.9, 19.5)   11 (5.5, 16.1)   4,503 (1,044, 9,541)   2.0 
Bulgaria   80 (2.1)   25.8 (9.4, 39.3)   25.8 (7.5, 39.3)   24.4 (13.3, 33.6)   943 (343, 1,437)   5.2 
Canada   42 (2.8)   16.3 (2.6, 32.4)   15.5 (3.8, 25.1)   14.6 (7.4, 20.9)   3,277 (518, 6,521)   4.4 
Chile   21 (1.8)   9.4 (3.0, 21.0)   8.5 (2.0, 14.4)   7.9 (3.9, 11.7)   279 (89, 627)   1.1 
China   34 (2.0)   15.9 (1.5, 38.1)   13.1 (3.2, 21.5)   12.4 (6.2, 18.0)   94,931 (8,999, 227,236)   4.3 
Croatia   50 (2.3)   19.3 (4.7, 33.2)   18.0 (4.7, 28.7)   16.9 (8.7, 24.0)   538 (132, 928)   4.0 
Cuba   5.2 (3.3)   4.3 (0.3, 20.1)   2.3 (0.5, 4.0)   2.1 (1.0, 3.2)   248 (15, 1,158)   1.0 
Cyprus   7.0 (2.6)   4.9 (0.5, 18.6)   3.1 (0.7, 5.3)   2.8 (1.3, 4.2)   13 (1, 48)   0.9 
Czech Republic   94 (1.8)   24.3 (11.6, 32.9)   28.9 (8.4, 43.3)   27.5 (15.2, 37.2)   1,271 (605, 1,720)   4.7 
Denmark   39 (2.2)   16.0 (3.8, 30.5)   14.6 (3.6, 23.8)   13.7 (6.9, 19.7)   607 (144, 1,162)   3.9 
Ecuador   70 (2.2)   23.3 (7.9, 35.9)   23.0 (6.2, 35.6)   22.2 (11.9, 30.8)   247 (83, 380)   1.8 
Egypt   6.6 (2.2)   5.9 (1.1, 18.0)   2.9 (0.7, 5.0)   2.6 (1.2, 4.0)   266 (47, 808)   0.4 
Estonia   44 (2.2)   16.3 (4.1, 29.8)   16.3 (4.1, 26.3)   15.3 (7.8, 21.9)   108 (27, 198)   3.0 
Finland   84 (2.1)   21.6 (7.8, 34.6)   26.5 (7.3, 40.3)   25.3 (13.8, 34.6)   462 (168, 740)   4.1 
France   50 (2.0)   19.4 (6.2, 32.5)   17.8 (4.6, 28.4)   16.9 (8.7, 24.0)   6,084 (1,957, 10,202)   3.9 
Germany   37 (2.2)   14.9 (3.6, 29.8)   14.0 (3.4, 22.9)   13.1 (6.6, 18.9)   6,449 (1,548, 12,950)   3.0 
Greece   44 (2.4)   15.5 (3.3, 29.2)   16.1 (4.0, 26.1)   15.2 (7.8, 21.8)   996 (213, 1,876)   3.5 
Hungary   62 (2.1)   23.3 (7.8, 36.0)   21.4 (5.8, 33.4)   20.1 (10.6, 28.2)   1,880 (633, 2,904)   6.2 
Iceland   7.3 (2.2)   4.2 (0.7, 13.1)   3.2 (0.7, 5.5)   2.9 (1.4, 4.4)   6 (1, 19)   1.1 
India   42 (2.2)   23.8 (6.6, 41.7)   15.6 (4.2, 25.1)   14.7 (7.5, 21.1)   15,175 (4,211, 26,612)   2.2 
Indonesia   35 (1.2)   17.5 (13.1, 22.7)   13.5 (3.4, 22.0)   12.5 (6.3, 18.2)   5,418 (4,047, 7,001)   2.8 
Iran   61 (2.2)   24.8 (8.0, 38.0)   20.8 (5.7, 32.6)   19.9 (10.5, 28.0)   1,080 (350, 1,657)   2.0 
Ireland   51 (2.4)   17.6 (3.9, 30.9)   18.1 (4.6, 29.0)   17.1 (8.9, 24.3)   313 (70, 550)   3.7 
Israel   23 (2.2)   11.1 (2.3, 27.4)   9.2 (2.1, 15.4)   8.6 (4.2, 12.7)   217 (45, 536)   2.0 
Italy   52 (2.1)   15.9 (4.5, 27.3)   18.3 (4.6, 29.3)   17.5 (9.1, 24.8)   5,327 (1,495, 9,147)   3.1 
Japan   10.4 (2.0)   4.2 (0.9, 11.7)   4.4 (0.9, 7.6)   4.1 (2.0, 6.2)   3,117 (688, 8,784)   0.8 
Kazakstan   11 (2.2)   7.9 (1.5, 23.1)   4.7 (1.1, 8.2)   4.3 (2.1, 6.5)   334 (63, 973)   1.4 
Kuwait   27 (1.9)   18.1 (0.4, 57.1)   10.5 (2.6, 17.5)   9.9 (4.9, 14.5)   15 (0, 48)   1.9 
Lithuania   37 (2.5)   16.9 (1.1, 46.1)   13.9 (3.4, 22.7)   12.9 (6.5, 18.7)   219 (15, 596)   2.6 
Luxembourg   70 (2.0)   21.9 (8.2, 32.4)   23.2 (6.3, 36.0)   22.1 (11.8, 30.7)   48 (18, 71)   4.7 
Malaysia   10 (2.2)   8.3 (1.6, 23.9)   4.4 (1.0, 7.6)   4.1 (1.9, 6.1)   342 (65, 990)   1.6 
Mexico   82 (1.3)   26.7 (20.3, 32.9)   25.9 (7.3, 39.5)   24.9 (13.6, 34.2)   2,030 (1,541, 2,503)   2.6 
Montenegro   50 (3.2)   24.4 (3.4, 51.8)   18.0 (5.0, 28.5)   16.9 (8.7, 24.0)   84 (12, 178)   6.2 
Netherlands   12 (2.0)   7.3 (0.9, 23.2)   5.2 (1.2, 8.9)   4.8 (2.3, 7.2)   773 (97, 2,466)   1.8 
New Zealand   20 (1.6)   10.2 (1.8, 27.3)   8.0 (1.8, 13.5)   7.4 (3.6, 11.0)   170 (30, 452)   2.0 
Norway   38 (3.2)   15.4 (1.7, 34.7)   14.3 (3.5, 23.4)   13.4 (6.8, 19.3)   341 (37, 769)   3.2 
Pakistan   52 (2.2)   24.0 (7.0, 39.2)   18.6 (5.1, 29.4)   17.4 (9.0, 24.6)   1,443 (420, 2,355)   1.4 
Paraguay   21 (2.2)   11.5 (2.4, 29.1)   8.4 (2.0, 14.1)   7.8 (3.8, 11.5)   76 (16, 192)   1.5 
Peru   24 (2.2)   13.1 (2.9, 30.5)   9.4 (2.2, 15.8)   8.9 (4.3, 13.0)   328 (72, 765)   1.3 
Philippines   22 (1.1)   12.3 (10.0, 15.0)   9.0 (2.2, 15.0)   8.3 (4.0, 12.2)   1,275 (1,033, 1,553)   2.2 
Poland   133 (1.9)   28.4 (15.8, 43.5)   36.1 (11.6, 51.8)   34.8 (20.3, 45.7)   6,639 (3,691, 10,174)   7.0 
Portugal   45 (2.2)   18.4 (4.8, 32.9)   16.5 (4.2, 26.5)   15.5 (8.0, 22.2)   633 (166, 1,132)   2.6 
Rep. of Korea   49 (2.0)   16.8 (5.3, 29.1)   17.5 (4.4, 28.1)   16.6 (8.5, 23.6)   2,993 (939, 5,197)   3.7 
Romania   84 (2.5)   26.3 (7.6, 48.4)   26.7 (7.8, 40.4)   25.4 (13.9, 34.7)   2,650 (762, 4,879)   5.5 
Russian Fed.   35 (2.2)   16.9 (3.9, 33.8)   13.6 (3.4, 22.3)   12.7 (6.4, 18.4)   8,583 (1,994, 17,191)   2.9 
Saudi Arabia   16 (2.2)   12.2 (2.5, 31.7)   6.7 (1.6, 11.4)   6.2 (3.0, 9.3)   90 (18, 233)   1.0 
Slovakia   48 (3.3)   19.7 (2.4, 45.8)   17.5 (4.5, 28.0)   16.3 (8.4, 23.3)   391 (47, 907)   3.3 
Slovenia   60 (2.2)   21.5 (6.2, 34.3)   20.7 (5.5, 32.5)   19.6 (10.3, 27.6)   243 (70, 388)   4.1 
Spain   53 (2.5)   18.5 (4.2, 32.4)   18.7 (4.8, 29.8)   17.8 (9.2, 25.1)   3,914 (883, 6,849)   3.8  
Note: BEIR VI, sixth Committee on Biological Effects of Ionizing Radiation exposure–age–concentration model; CI, confidence interval; GM, geometric mean; GSD, geometric stand-
ard deviation; PAR, population attributable risk. 
aSources of the national radon GMs and GSDs listed in column 2 are described in Table S1. 
bEstimate of PAR based on the BEIR VI EAC model for excess rate ratio. 
cEstimate of PAR based on the Hunter et al. (2013) model for excess rate ratio. 
dEstimate of PAR based on the Kreuzer et al. (2015) model for excess rate ratio. 
ePercentage of total cancer deaths represented by the mean radon-attributable number of lung cancer deaths estimated using the BEIR VI EAC model for excess rate ratio.  
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the PAR of lung cancer mortality is given by the ratio of the sum of 
the attributable lung cancer deaths (over all age–sex–smoking cate-
gories) to the total number of lung cancer deaths. 
Validation 
The validity of the approach was assessed by comparing the results 
for Canada for radon PAR of lung cancer mortality from the attribut-
able fraction approach to an alternative life-table analysis. The 
abridged period life-table approach will use 5-y-age intervals, and 
age- and sex-specific all-cause and lung cancer mortality rates will 
be calculated from the census and death database. The probabilities 
of death reported in the death database were first converted into mor-
tality rates, so that an exposed person’s risk can be modeled as the 
sum of the baseline risk and the risk due to radon exposure, 
expressed in terms of an intensity ratio. The excess rate ratio used to 
model the risk due to radon exposure in the life-table analysis is the 
BEIR VI EAC model described earlier. The probability of surviving 
to the beginning of each age interval, the probability of dying during 
the age interval, and the intensity ratio between all-cause and lung 
cancer mortality are used to determine baseline and exposed life ex-
pectancy (LE; LEE) and lifetime risk (LR; LRE) of lung cancer. The 
PAR (Equation 2) is calculated from the population-averaged life-
time risk in the exposed (LRE) and the baseline lifetime risk for a 





: (2)  
Results 
The GMs of the national residential radon distributions around 
the world are shown in Figure 1. The national residential radon 
distributions for the 66 countries around the world are listed in 
Table 1 and the national adult male and female smoking preva-
lence distributions in Table S2. Geometric mean radon exposures 
for the 66 countries ranged from 133 Bq=m3 for Poland to 
5 Bq=m3 for Cuba, with a median of 38 Bq=m3. The median adult 
smoking prevalence was 35% for males and 18% for females. 
The estimates of the national radon PAR of lung cancer mortal-
ity for the 66 countries included in the present analysis are listed in 
Table 1 for the BEIR VI EAC model, the Hunter et al. (2013) 
model restricted to <300 WLM, and the Kreuzer et al. (2015) 
model for excess rate ratio. The mean PAR using the BEIR VI 
EAC model ranged from 4.2% (95% CI: 0.9, 11.7) for Japan to 
29.3% (95% CI: 22.9, 35.7) for Armenia, with a median for the 66 
countries of 16.5%. The three estimates are consistent, with the me-
dian for the 66 countries of 16.5%, 14.4%, and 13.6% for the BEIR 
VI EAC model, the Hunter model and the Kreuzer model, respec-
tively. One difference between the three estimates results from the 
higher excess rate ratio for nonsmokers compared to smokers in 
the BEIR VI EAC model; a higher mean PAR is estimated for 
Mexico, at 26.7%, than for Romania, at 26.3%, despite Mexico 
having a slightly lower GM radon than Romania, at 82 and 
84 Bq=m3, respectively, because the smoking prevalence for males 
and females are lower in Mexico than in Romania. A lower mean 
PAR is estimated for Mexico than for Romania using the Hunter 
model, at 25.9% for Mexico and 26.7% for Romania, and using the 
Kreuzer model, at 24.9% for Mexico and 25.4% for Romania. 
Estimates of the number radon-attributable lung cancer deaths 
using the BEIR VI EAC model for the 66 countries totaled 226,057 
in 2012 are also listed in Table 1. The most populous country in the 
world, China, is the country with the highest estimated number of 
radon-attributable lung cancer deaths, at 94,931 (95% CI: 8,999, 
227,236). The United States is ranked second, with 20,925 (95% 
CI: 2,137, 51,296) radon-attributed lung cancer deaths in 2012, 
and India is ranked third, with 15,175 (95% CI: 4,211, 26,612). 
Radon-attributable lung cancer deaths represented a median of 
3.0% of total cancer deaths for the 66 countries, ranging from 7.0% 
for Poland down to 0.4% for Egypt. 
Validation 
An alternative life table analysis was conducted for Canada using 
the 2012 age- and sex-specific all-cause and lung cancer mortality 
rates, using 10,000 simulations of the BEIR VI EAC model for the 
excess rate ratio from radon. The mean PAR in Canada for lung 
cancer mortality from radon was estimated to be 14.7% (95% CI: 
2.0, 30.0) from the life table analysis, which was similar to the 
PAR estimate of 16.3% (95% CI: 2.6, 32.4) from the main analysis 
for Canada derived from the attributable fraction approach using 
the BEIR VI EAC model. The life table analysis for Canada esti-
mated PAR for males at 13.2% (95% CI: 1.7, 26.7), for male non-
smokers at 19.8% (95% CI: 2.7, 40.0), and for male smokers at 
10.9% (95% CI: 1.4, 22.3) and PAR for females at 16.5% (95% CI: 
2.2, 33.3), for female nonsmokers at 21.2% (95% CI: 3.0, 41.9), 
and for female smokers at 13.4% (95% CI: 1.7, 27.7). 
Published estimates of national PAR of lung cancer mortality 
from residential radon exposure for another eight countries are com-
pared to the estimates from this analysis in Table 2. The methodolo-
gies used in these studies included the attributable fraction approach, 
the period life table analysis, and one study that used the cohort life ta-
ble analysis; whereas the excess relative risk of lung cancer from ra-
don was modeled using the estimate from pooled case–control 
residential studies in Europe and North America based on a 30-y ex-
posure period and the BEIR VI EAC model, which is based on life-
time exposure from extrapolation of miner studies. 
Discussion 
The estimates of PAR for lung cancer mortality from residential ra-
don for the 66 countries are very similar for the three excess rate ra-
tio models used in this analysis: the median PAR was 16.5% using 
the BEIR VI EAC model, 14.4% using the Hunter et al. (2013) 
Table 1. (Continued.) 
Country 
Radona [GM (GSD)]  
(Bq=m3) 
PAR (%), BEIR VIb  
[mean (95% CI)] 
PAR (%), Hunterc  
[mean (95% CI)] 
PAR (%), Kreuzerd  
[mean (95% CI)] 
Attributable number  
lung cancer deaths,  
BEIR VIb [mean (95% CI)] 
Total Cancer  
Deathse (%)  
Sweden   67 (2.2)   19.2 (6.0, 30.3)   22.4 (5.9, 34.9)   21.2 (11.3, 29.6)   710 (220, 1,119)   3.2 
Switzerland   51 (2.3)   19.6 (1.4, 49.5)   18.2 (4.7, 29.0)   17.2 (8.9, 24.4)   627 (46, 1,580)   3.8 
Syria   33 (2.2)   16.3 (4.0, 33.8)   12.6 (3.2, 20.7)   11.7 (5.9, 17.1)   298 (74, 617)   2.1 
Thailand   16 (1.2)   9.4 (6.7, 12.6)   6.7 (1.6, 11.3)   6.2 (3.0, 9.2)   1,660 (1,191, 2,228)   2.0 
Tunisia   34 (2.2)   17.5 (4.2, 34.8)   13.0 (3.3, 21.2)   12.1 (6.1, 17.6)   271 (66, 541)   3.7 
Turkey   57 (2.3)   24.7 (6.9, 40.0)   20.1 (5.6, 31.4)   18.9 (9.9, 26.6)   5,422 (1,509, 8,773)   5.9 
United Kingdom   14 (3.2)   8.0 (0.6, 26.5)   5.8 (1.3, 10.1)   5.4 (2.6, 8.1)   2,858 (219, 9,419)   1.8 
USA   25 (3.1)   12.5 (1.3, 30.6)   9.9 (2.3, 16.7)   9.3 (4.6, 13.6)   20,925 (2,137, 51,296)   3.4 
Venezuela   39 (2.2)   19.4 (4.9, 36.1)   14.5 (3.7, 23.6)   13.7 (6.9, 19.7)   746 (188, 1,391)   3.2   
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restricted model, and 13.6% using the Kreuzer et al. (2015) model. 
The estimates support the use of models based on miner studies, 
with the two miner models based on low radon exposure rates and 
cumulative doses that approximate those resulting from lifetime 
residential exposures yielding PARs close to those from the BEIR 
VI EAC model. The BEIR VI EAC model is the most complete 
excess rate ratio model, including factors for smoking status, time 
since exposure, radon exposure rate, and attained age. The three 
excess rate ratio models used in this analysis to estimate PAR 
were based on lifetime exposure, calculated from lifetime risk as 
presented in Equation 2. Four excess rate ratio models, including 
the three in this analysis, were used in Hunter et al. (2015) to esti-
mate risk of exposure-induced death from residential radon expo-
sure between 30 and 75 y of age. The fourth excess rate ratio model 
included in Hunter et al. (2015) was the model derived from the 
European pooled residential study; after corrections for uncertain-
ties in radon measurement, the European pooled residential radon 
study estimate of ERR = 0:16 per 100 Bq=m3 radon exposure 5–35 y 
prior to lung cancer (Darby et al. 2006) was found to be equivalent to 
an ERR=WLM = 0:12, very close to the ERR=WLM = 0:13 derived 
from the Kreuzer et al. (2015) miner model based on low radon expo-
sure rates (Hunter et al. 2015). 
The studies of radon-attributed lung cancer mortality in min-
ers were characterized by far superior radon exposure assess-
ment, based on annual measurements of radon for each year a 
miner was exposed, whereas the residential radon studies relied 
on only one or two measurements for the entire 30-y period of 
exposure considered. It is reassuring that estimates of PAR 
derived from extension of the pooled residential studies, after 
restriction to the better radon exposure measurement, were 
comparable though lower (see Table S3) than those derived 
from the miner cohort studies. Any degree of residential mobil-
ity has a severe impact on the precision of residential radon ex-
posure in the pooled case–control studies. The excess relative 
risk per 100 Bq=m3 radon increased from 8% to 16% when the 
European analysis was adjusted for the random uncertainties 
from using limited measurements of residential radon (Darby 
et al. 2006). Similarly, after consideration of spatial mobility of 
participants, the ERR per 100 Bq=m3 radon in the North 
American pooled residential study increased from 10% to 18% 
when the analysis was restricted to individuals with measure-
ments for at least 20 of the 25 y of radon exposure (Krewski 
et al. 2006). As noted by Field and Withers (2012), any remaining 
nondifferential radon exposure measurement error would tend to 
Figure 1. World map of geometric means of national residential radon exposures [in becquerels per cubic meter (Bq=m3)]. For more information, see Table 
S1. (Plotted using R package rworldmap; R Core Team.)  
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bias the observed association toward the null and it is quite possible 
that more precise radon measurement in residential studies (such as 
based on annual radon levels) would result in a higher estimate for 
ERR. The policy implications from basing decisions on epidemio-
logic studies with significant measurement error in environmental 
exposure and outcomes have been discussed recently by Edwards 
and Keil (2017). 
The Global Burden of Disease Study 2010 (Lozano et al. 
2012) reported that the number of lung cancer deaths globally 
has increased by 47% between 1990 and 2010, to 1,527.1 (95% 
CI: 1,126.3, 1,779.4) thousand deaths. Tobacco use remains the 
most important risk factor for lung cancer, but characterizing the 
contribution of other modifiable risk factors, such as exposure to 
radon and to outdoor air particulates, is necessary to reduce the 
burden of lung cancer mortality. The estimates of the global PAF 
of lung cancer mortality in 2012 from radon, ranging from 16.5% 
to 13.6%, were comparable to the 12.8% attributable to outdoor 
air particulates (PM2:5) (Evans et al. 2013). This analysis demon-
strates that residential radon is a significant and modifiable risk 
factor for lung cancer mortality worldwide. 
The demographics of a country affect the national number of 
lung cancer deaths. Lung cancer mortality increases with age, so 
countries with higher life expectancies have a greater number of 
lung cancer deaths. In 2012, life expectancy was 79 y in the United 
States and 68 y in India (World Bank 2014). Even though the radon 
exposure is higher and the population is much greater in India than 
in the United States, there are more lung cancer deaths attributed to 
radon in the United States (20,925) than in India (15,175). 
The validity of estimating the radon ERR of lung cancer mortal-
ity from the attributable fraction approach is supported by the results 
from the attributable fraction approach and the life table analysis for 
Canada, with PARs of 16.3% (95% CI: 2.6, 32.4) and 14.7% (95% 
CI: 2.0, 30.0), respectively. Similar results were reported for the 
Canadian province of Ontario from a life table analysis (Peterson 
et al. 2013) using the same BEIR VI EAC model for excess rate ra-
tio: an overall PAR of 13.6%, with PARs of 21.9% for never smok-
ers and 12.3% for ever smokers [radon distribution GM (GSD): 
43 ð3:1ÞBq=m3 for Ontario and 41:9 ð2:8ÞBq=m3 for Canada]. A 
life table analysis for Canada also based on a BEIR VI model for 
excess rate ratio reported a comparable estimate of radon PAR of 
lung cancer mortality of 16% (Chen et al. 2012). 
The estimates determined in this analysis were compared with 
published national estimates of PARs for eight other countries in 
Table 2. The estimates in Table 2 determined using the excess 
rate ratio derived from the pooled residential studies were 
roughly half those using the BEIR VI models, following the pat-
tern observed for the estimates of PAR determined in this analy-
sis. The PARs determined using the excess rate ratio from pooled 
residential studies were closer when corrected for uncertainties in 
the exposure assessment to those using the BEIR VI EAC model 
for both France (Catelinois et al. 2006), at 11% and 12%, respec-
tively, and for Germany (Menzler et al. 2008), at 7% and 12%, 
respectively. Use of the ERR estimate from the residential studies 
assumes that radon exposure >30 y prior does not contribute to 
lung cancer. The BEIR VI EAC model uses relative weights to 
progressively diminish the contribution of radon exposure 15–24 y 
prior and >25 y prior to the outcome, and the Hunter et al. (2013) 
model diminishes the contribution to one-sixth for exposure >25 y 
prior to the outcome. However, it is not surprising that PAR 
estimates of lung cancer mortality from radon based on lifetime 
exposure are higher than those limited to exposure 30 y prior to 
lung cancer mortality. 
The studies listed in Table 2 also used various measures of ra-
don exposure: the arithmetic mean national exposure for the 
Netherlands and Sweden (Leenhouts and Brugmans 2001) and 
the radon distribution for the United Kingdom (HPA 2009) and the 
United States (NRC 1999), whereas regional radon distributions 
were used for the estimate for France (Catelinois et al. 2006), 
Germany and Switzerland (Menzler et al. 2008), and South Korea 
(Lee et al. 2015). The published regional analysis for France 
reported a smaller PAR estimate (13% vs. 19.4%), whereas the re-
gional analysis for South Korea reported a larger PAR estimate of 
22% versus 16.8% when compared with the results from the 
national analysis used in this study (using the EAC risk model). 
The estimates from published studies that also used a national anal-
ysis were much closer to the results from this study (for the EAC ra-
don model), the United States (13.9% vs. 12.5%), and the United 
Kingdom (6% vs. 8%). 
Table 2. Comparison of national estimates of PAR of lung cancer mortality from radon. 
Country 
PAR estimates (%) [mean (95% CI)]a Published estimates 
BEIR VI EAC Hunter Kreuzer PAR (ERR model)b Methodology Reference   
France   19.4 (6.2, 32.5)   17.8 (4.6, 28.4)   16.9 (8.7, 24) 13 (EAC)  
5 (Euro. pooled)  
2 (N. Am. pooled)  
11 (N. Am. pooled cor.) 
Attributable fraction,  
regional analysis 
Catelinois et al. 2006 
Germany   14.9 (3.6, 29.8)   14.0 (3.4, 22.9)   13.1 (6.6, 18.9) 12 (EAC)  
3.1 (Euro. pooled)  
7.3 (Euro. pooled cor.) 
Period life table Menzler et al. 2008 
Netherlands   7.3 (0.9, 23.2)   5.2 (1.2, 8.9)   4.8 (2.3, 7.2) 3 (2-mutation carc.) Cohort life table Leenhouts and  
Brugmans 2001 
Sweden   19.2 (6.0, 30.3)   22.4 (5.9, 34.9)   21.2 (11.3, 29.6) 19 (2-mutation carc.) Cohort life table Leenhouts and  
Brugmans 2001 
Switzerland   19.6 (1.4, 49.5)   18.2 (4.7, 29.0)   17.2 (8.9, 24.4) 8.3 (Euro. pooled) Period life table Menzler et al. 2008 
South Korea   16.8 (5.3, 29.1)   17.5 (4.4, 28.1)   16.6 (8.5, 23.6) 22 (EAC)  
8.3 (Euro. pooled) 
Attributable fraction,  
regional analysis 
Lee et al. 2015 
United States   12.5 (1.3, 30.6)   9.9 (2.3, 16.7)   9.3 (4.6, 13.6) 13.9 (EAC) Period life table NRC 1999 
United Kingdom   8.0 (0.6, 26.5)   5.8 (1.3, 10.1)   5.4 (2.6, 8.1) 6.0 (EAC)  
3.3 (Euro. pooled cor.) 
Period life table HPA 2009 
Note: BEIR VI EAC, sixth Committee on Biological Effects of Ionizing Radiation exposure–age–concentration model; CI, confidence interval; ERR, excess risk ratio; Euro. pooled, 
European pooled study; Euro. pooled cor., European pooled study corrected for random uncertainties in radon measurement; N. Am. pooled, North American pooled study; N. Am. 
pooled cor., North American pooled study corrected for random uncertainties in radon measurement (restricted to lower residential mobility); PAR, population attributable risk; 2- 
mutation carc., two-mutation carcinogenesis model (a biologically based carcinogenesis model). 
aBrief information about the three models for excess rate ratio used in this analysis: BEIR IV EAC, BEIR VI EAC model; Hunter, Hunter et al. (2013) model; Kreuzer, Kreuzer et al. 
(2015) model. 
bInformation about the models used in published studies: Euro. pooled: ERR = 0:08 per 100 Bq=m3 radon; N. Am. pooled: ERR = 0:1 per 100 Bq=m3 radon; N. Am. pooled cor. 
ERR = 0:18 per 100 Bq=m3 radon; Euro. pooled cor. ERR = 0:16 per 100 Bq=m3 radon.  
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The results of this analysis must be interpreted cautiously due 
to the uncertainty associated with the national radon exposures. 
Many countries have not conducted a population representative 
national survey, and very few countries have conducted more 
than one representative national radon survey. A population rep-
resentative national radon survey requires long-term radon mea-
surement, 3–12 months in duration, in several hundred to several 
thousand randomly selected dwellings. Some uncertainty is also 
associated with the excess rate ratio model for lung cancer mortal-
ity from radon, as indicated by the range in PAR values resulting 
from the different excess rate ratio models used in this analysis. 
The use of the BEIR VI EAC model resulted in the highest estimate 
of median PAR (16.5%) and the use of excess rate ratios based on 
the pooled residential studies resulted in the lowest estimates 
(10.4% for North American; 8.4% for European), whereas the 
excess rate ratio models from the recent low-dose miner cohort 
resulted in intermediate estimates of PAR [14.4% for Hunter et al. 
(2013); 13.6% for Kreuzer et al. (2015)]. 
Representative national surveys of residential radon are required 
in all countries to better characterize the global burden of lung can-
cer mortality attributed to radon. Reducing the burden of lung cancer 
mortality and morbidity attributed to radon will depend on future 
research into the practical implementation and cost effectiveness of 
interventions to reduce radon exposures and improved education 
and awareness about radon. Many countries could benefit from a ra-
don reduction intervention such as the installation of a soil gas mem-
brane at the time of construction, as determined for Norway (Stigum 
et al. 2003), the United Kingdom (Gray et al. 2009), and Ireland 
(Pollard and Fenton 2014). A highly effective intervention, such as 
active sub-slab depressurization, might prove cost effective in coun-
tries or regions with higher burdens from radon-attributed lung can-
cer mortality and substantial investment in healthcare. 
Conclusions 
Representative national surveys of residential radon exposures 
were available for 66 countries around the world. The estimates 
of the PAR of lung cancer mortality from residential radon expo-
sure for 2012 were very consistent for the 66 countries, with a 
median PAR of 16.5%, 14.4%, and 13.6% from the three excess 
rate ratio models [BEIR VI EAC, Hunter et al. (2013) restricted, 
and Kreuzer et al. (2015) unrestricted, respectively]. An alterna-
tive methodological approach, the period life table analysis, was 
conducted for Canada, and yielded an estimate of PAR of 14.7% 
(95% CI: 2.0, 30.0) that was very close to the PAR of 16.3% 
(95% CI: 2.6, 32.4) determined from the attributable fraction 
approach. This study provides an estimate of the global burden 
from lung cancer attributable to radon, pending more complete 
data on national radon exposures. 
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